HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia.

Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine.

1986 • 280 citations

An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults

1984 • 256 citations

Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphoma and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society.

1986 • 204 citations

Central nervous system toxicity of high-dose systemic cytosine arabinoside

1981 • 204 citations

Prolonged complete remission following high dose chemotherapy of burkitt's lymphoma in relapse

1978 • 152 citations

Curability of Burkitt's lymphoma with high-dose cyclophosphamide-high-dose methotrexate therapy and intrathecal chemoprophylaxis.

1985 • 75 citations

Paraparesis following intrathecal cytosine arabinoside.A case report with neuropathologic findings

1977 • 70 citations

Management of childhood non-Hodgkin's lymphoma.

1977 • 53 citations

Massive BACT chemotherapy with autologous bone marrow transplantation in 17 cases of non-Hodgkin's malignant lymphoma with a very bad prognosis

1983 • 51 citations

Effective therapy for Burkitt's lymphoma: High-dose cyclophosphamide + high-dose methotrexate with coordinated intrathecal therapy

1979 • 21 citations

Patterns of treatment failure in Burkitt's lymphoma

1983 • 13 citations

Cited By (0)

Loading...